• Explore /
  • Poster
  • / Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.

Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.

Abstract Poster

Authors

null

Michael Michael

Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia

Michael Michael , Rachel Wong , Sanjeev Singh Gill , David Goldstein , Sam Ngan , Alexander Graham Heriot , Emma Link , Maria Farrell , Paul J Neeson , Robert George Ramsay , Kasmira Wilson , Catherine Mitchell , Jeanne Tie , Nick Pavlakis , John Raymond Zalcberg , Eva Segelov

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT03299660

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS3622)

DOI

10.1200/JCO.2019.37.15_suppl.TPS3622

Abstract #

TPS3622

Poster Bd #

110b

Abstract Disclosures

Similar Posters

First Author: Michael Michael

First Author: Lisa Salvatore

First Author: Zhenyu Lin

First Author: Simon Gollins